Skip to main content
SpringerLink
Log in

Expression of TrkA, TrkB and TrkC in human neuroblastomas

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

There is considerable interest in the role of the TRK family of neurotrophin receptors in regulating the survival, growth and differentiation of normal and neoplastic nerve cells. Indeed, there is increasing evidence that TRK genes play an important role in the biology and clinical behavior of neuroblastomas, tumors of the peripheral nervous system. Evidence from several independent studies suggests that high expression of TrkA is an indicator of favorable outcome, and there is an inverse correlation between TrkA expression and N-myc amplification. In addition, some primary neuroblastomas differentiate in vitro in the presence of NGF but die in its absence. We have evidence that coexpression of full-length TrkB and BDNF is associated with N-myc amplification and may represent an autocrine survival pathway. Conversely, truncated TrkB is expressed predominantly in differentiated tumors. Finally, TrkC is expressed in favorable neuroblastomas, essentially all of which also express TrkA. In summary, the study of neurotrophin receptor expression and function in neuroblastomas may provide important insights into the role that these pathways play in the pathogenesis and clinical behavior of this tumor. Ultimately, these pathways may provide attractive targets for the development of therapy aimed at inducing differentiation or programmed cell death in these tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baker DL, Reddy UR, Pleasure D, Thorpe CL, Evans AE, Cohen PS, Ross AH: Analysis of nerve growth factor receptor expression in human neuroblastoma and neuroepithelioma cell lines. Cancer Res 49: 4142–4146, 1989

    Google Scholar 

  2. Azar CG, Scavarda NJ, Reynolds P, Brodeur GM: Multiple defects of the nerve growth factor receptor in human neuroblastomas. Cell Growth Diff 1: 421–428, 1990

    Google Scholar 

  3. Ernfors P, Ibanez CF, Ebendal T, Olson L, Persson H: Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci USA 87: 5454–5458, 1990

    Google Scholar 

  4. Hohn A, Leibrock J, Bailey K, Barde Y-A: Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 344: 339–341, 1990

    Google Scholar 

  5. Jones KR, Reichardt LF: Molecular cloning of a human gene that is a member of the nerve growth factor family. Proc Natl Acad Sci USA 87: 8060–8064, 1990

    Google Scholar 

  6. Rosenthal A, Goeddel DV, Nguyen T, Lewis M, Shih A, Laramee GR, Nikolics K, Winslow JW: Primary structure and biological activity of a novel human neurotrophic factor. Neuron 4: 767–773, 1990

    Google Scholar 

  7. Maisonpierre PC, Belluscio L, Squinto S, Ip NY, Furth ME, Lindsay RM, Yancopoulos GY: Neurotrophin-3: A neurotrophic factor related to NGF and BDNF. Science 247: 1446–1451, 1990

    Google Scholar 

  8. Berkemeier LR, Winslow JW, Kaplan DR, Nikolics K, Goeddel DV, Rosenthal A: Neurotrophin-5: A novel neurotrophic factor that activates trk and trkB. Neuron 7: 857–866, 1991

    Google Scholar 

  9. Hallbook F, Ibanez CF, Persson H: Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron 6: 845–858, 1991

    Google Scholar 

  10. Hempstead BL, Martin-Zanca D, Kaplan DR, Parada LF, Chao MV: High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature 350: 678–683, 1991

    Google Scholar 

  11. Kaplan DR, Hempstead BL, Martin-Zanca D, Chao MV, Parada LF: The trk proto-oncogene product: A signal transducing receptor for nerve growth factor. Science 252: 554–558, 1991

    Google Scholar 

  12. Klein R, Jing S, Nanduri V, O'Rourke E, Barbacid M: The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 65: 189–197, 1991

    Google Scholar 

  13. Klein R, Nanduri V, Jing S, Lamballe F, Tapley P, Bryant S, Cordon-Cardo C, Jones KR, Reichardt LF, Barbacid M: The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell 66: 395–403, 1991

    Google Scholar 

  14. Lamballe F, Klein R, Barbacid M: trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell 66: 967–979, 1991

    Google Scholar 

  15. Squinto SP, Stitt TN, Aldrich TH, Davis S, Bianco SM, Radziejewski C, Glass DJ, Masiakowski P, Furth ME, Valenzuela DM, DiStefano PS, Yancopoulos GD: trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell 65: 885–893, 1991

    Google Scholar 

  16. Ip NY, Ibanez CF, Nye SH, McClain J, Jones PF, Gies DR, Belluscio L, Le Beau MM, Espinsosa III R, Squinto SP, Persson H, Yancopoulos GD: Mammalian neurotrophin-4: Structure, chromosomal localization, tissue distribution, and receptor specificity. Proc Natl Acad Sci USA 89: 3060–3064, 1992

    Google Scholar 

  17. Klein R, Lamballe F, Bryant S, Barbacid M: The trkB tyrosine protein kinase is a receptor for neurotrophin-4. Neuron 8: 947–956, 1992

    Google Scholar 

  18. Chao MV, Bothwell MA, Ross AH, Koprowski H, Lanahan AA, Buch CR, Sehgal A: Gene transfer and molecular cloning of the human NGF receptor. Science 232: 518–521, 1986

    Google Scholar 

  19. Johnson D, Lanahan AA, Buck CR, Sehgal A, Morgan C, Mercer E, Bothwell MA, Chao MV: Expression and structure of the human NGF receptor. Cell 47: 545–554, 1986

    Google Scholar 

  20. Martin-Zanca D, Oskam R, Mitra G, Copeland T, Barbacid M: Molecular and biochemical characterization of the human trk proto-oncogene. Mol Cell Biol 9: 24–33, 1989

    Google Scholar 

  21. Jing S, Tapley P, Barbacid M: Nerve growth factor mediates signal transduction through trk homodimer receptors. Neuron 9: 1067–1079, 1992

    Google Scholar 

  22. Meakin SO, Shooter EM: Tyrosine kinase activity coupled to the high-affinity nerve growth factor-receptor complex. Proc Natl Acad Sci USA 88: 5862–5866, 1991

    Google Scholar 

  23. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, Yancopoulos GD: ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65: 663–675, 1991

    Google Scholar 

  24. Vetter ML, Martin-Zanca D, Parada LF, Bishop MJ, Kaplan DR: Nerve growth factor rapidly stimulated tyrosine phosphorylation of phospholipase C-γ1 by a kinase activity associated with the product of the trk protooncogene. Proc Natl Acad Sci USA 88: 5650–5654, 1991

    Google Scholar 

  25. Milbrandt J: Nerve growth factor rapidly induces c-fos mRNA in PC12 rat pheochromocytoma cells. Proc Natl Acad Sci USA 83: 4789–4793, 1986

    Google Scholar 

  26. Milbrandt J: A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 238: 797–799, 1987

    Google Scholar 

  27. Milbrandt J: Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron 1: 183–188, 1988

    Google Scholar 

  28. Fearon E, Cho K, Nigro J, Kern S, Simons J, Ruppert J, Hamilton S, Presinger A, Thomas G, Kinzler K, Vogelstein B: Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247: 49–56, 1990

    Google Scholar 

  29. Lawler K, G., Narayanan R: Persistent expression of the tumor suppressor gene DCC is essential for neuronal differentiation. Cell Growth Diff 3: 609–616, 1992

    Google Scholar 

  30. Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM: Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res 52: 1364–1368, 1992

    Google Scholar 

  31. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM: Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. New Engl J Med 328: 847–854, 1993

    Google Scholar 

  32. Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM: Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol 14: 759–767, 1994

    Google Scholar 

  33. Nakagawara A, Arima-Nakagawara M, Azar CG, Scavarda NJ, Brodeur GM: Clinical significance of expression of neurotrophic factors and their receptors in neuroblastoma. In: Evans AE, Brodeur GM, D'Angio GJ, Nakagawara A (eds) Advances in Neuroblastoma Research 4. Wiley-Liss, New York, 1994, pp 155–161

    Google Scholar 

  34. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224: 1121–1124, 1984

    Google Scholar 

  35. Azar CG, Nakagawara A, Scavarda NJ, Brodeur GM: Partial restoration of NGF responsiveness by transfection of neuroblastoma cell lines with TRK-A. Oncogene 1996 (in press)

  36. Azar CG, Scavarda NJ, Nakagawara A, Brodeur GM: Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines. In: Evans AE, Brodeur GM, D'Angio GJ, Nakagawara A (eds) Advances in Neuroblastoma Research 4. Wiley-Liss, New York, 1994, pp 165–175

    Google Scholar 

  37. Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger RC: lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J Natl Cancer Inst 85: 377–384, 1993

    Google Scholar 

  38. Kogner P, Barbany G, Dominici C, Castello MA, Raschella G, Persson H: Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res 53: 2044–2050, 1993

    Google Scholar 

  39. Borrello MG, Bongarzone I, Pierotti MA, Luksch R, Gasparini M, Collini P, Pilotti S, Rizzetti MG, Mondellini P, De-Bernardi B, DiMartino D, Garaventa A, Brisigotti M, Tonini GP: TRK and RET protooncogene expression in human neuroblastoma specimens: High-frequency of TRK expression in non-advanced stages. Intl J Cancer 54: 540–545, 1993

    Google Scholar 

  40. Yamashiro DJ, Nakagawara A, Ikegaki N, Liu X-G, Brodeur GM: Expression of TrkC in favorable human neuroblastomas. Oncogene 12: 37–41, 1996

    Google Scholar 

  41. Nakagawara A, Milbrandt J, Muramatsu T, Deuel TF, Zhao H, Cnaan A, Brodeur GM: Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res 55: 1792–1797, 1995

    Google Scholar 

  42. Sendtner M, Kreutzberg GW, Thoenen H: Ciliary neurotropic factor prevents the degeneration of motor neurons after axotomy. Nature 345: 440–441, 1990

    Google Scholar 

  43. Davis S, Aldrich TH, Valenzuela DM, Wong V, Furth ME, Squinto SP, Yancopoulos GD: The receptor for ciliary neurotrophic factor. Science 253: 59–63, 1991

    Google Scholar 

  44. Brodeur GM: Neuroblastoma: Clinical significance of genetic abnormalities. Cancer Surv 9: 673–688, 1990

    Google Scholar 

  45. Brodeur GM, Nakagawara A: Molecular basis of clinical heterogeneity in neuroblastoma. Am J Pediatr Hematol Oncol 14: 111–116, 1992

    Google Scholar 

  46. Acheson A, Barker PA, Alderson RF, Miller FD, Murphy RA: Detection of brain-derived neurotrophic factor-like activity in fibroblasts and Schwann cells: Inhibition by antibodies to NGF. Neuron 7: 265–275, 1991

    Google Scholar 

  47. Brodeur GM, Nakagawara A: Clinical significance of expression of neurotrophic factors and their receptors in neuroblastomas. Perspect Devel Neurobiol 1996 (in press)

Download references

Author information

Authors and Affiliations

  1. Division of Oncology, Children's Hospital of Philadelphia, USA

    Garrett M. Brodeur, Akira Nakagawara, Darrell J. Yamashiro, Naohiko Ikegaki, Xing-Ge Liu, Christopher G. Azar, Catherine P. Lee & Audrey E. Evans

  2. Department of Pediatrics, University of Pennsylvania, Abramson Research Center, Room 902D, 324 South 34th Street, Philadelphia, PA, 19104—4813, USA

    Garrett M. Brodeur

Authors
  1. Garrett M. Brodeur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akira Nakagawara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Darrell J. Yamashiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Naohiko Ikegaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xing-Ge Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Christopher G. Azar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Catherine P. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Audrey E. Evans
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brodeur, G.M., Nakagawara, A., Yamashiro, D.J. et al. Expression of TrkA, TrkB and TrkC in human neuroblastomas. J Neurooncol 31, 49–56 (1997). https://doi.org/10.1023/A:1005729329526

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005729329526

Search

Navigation